The Economic Times daily newspaper is available online now.

    Everstone buys Malaysian medical devices company Chemopharm

    Synopsis

    The deal will be carried out via Everlife, the Singapore-headquartered fund said in a statement today without offering the deal value.

    dealThinkStock Photos
    The deal is done through a Singaporean partner Cure Capital as a co-investor.
    NEW DELHI: The Everstone Group has acquired Malaysia-based diagnostics and medical supplies distributor Chemopharm for an undisclosed sum. Singapore-based Cure Capital acted as a co-investor in the transaction.

    Chemopharm has distribution presence in Singapore, Thailand, Indonesia, Vietnam and the Philippines, and caters to a wide set of customers that includes hospitals, laboratories and research facilities.

    “There is a critical need for scaled distributors with strong capabilities, which can provide regional access to the fragmented markets of Southeast Asia,” said Amit Manocha, Everstone Group managing director.

    The private equity group, which manages investments of about $4 billion, is also an investor in Indian pharmaceutical distribution platform Ascent.

    The Everstone Group exited its investment in Hyderabad-based Global Hospitals two years ago by selling its stake to an arm of Malaysian sovereign wealth fund Khazanah, marking its first successful exit from its India healthcare portfolio.


    (You can now subscribe to our Economic Times WhatsApp channel)
    ( Originally published on Nov 23, 2017 )
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more

    (You can now subscribe to our Economic Times WhatsApp channel)
    (Catch all the Business News, Breaking News Budget 2024 News, Budget 2024 Live Coverage, Events and Latest News Updates on The Economic Times.)

    Download The Economic Times News App to get Daily Market Updates & Live Business News.

    ...more
    The Economic Times

    Stories you might be interested in